# HIV Class Visualizations
## Educational Graphics and Diagrams for HIV Teaching

---

## 1. HIV Virus Structure

**Description:** Detailed 3D illustration of HIV virus structure

**Visual Elements:**
- **Outer Envelope:** gp120/gp41 spike proteins
- **Matrix Layer:** p17 protein
- **Capsid:** p24 protein core containing RNA
- **Viral Enzymes:** Reverse transcriptase, integrase, protease
- **RNA Genome:** Two identical strands

**Labels:**
- Color-coded components
- Function annotations
- Scale representation
- Comparison with other viruses

---

## 2. HIV Replication Cycle

**Description:** Step-by-step circular diagram of HIV replication

**Cycle Steps:**
1. **Attachment:** gp120 binds CD4 + co-receptor
2. **Entry:** Fusion and uncoating
3. **Reverse Transcription:** RNA â†’ DNA
4. **Integration:** Viral DNA into host genome
5. **Transcription:** Viral mRNA production
6. **Translation:** Viral proteins synthesis
7. **Assembly:** New virions formation
8. **Budding:** Release of mature virus

**Visual Elements:**
- Circular flow diagram
- Color progression (blue to red)
- Molecular animations
- Time indicators
- Drug intervention points

---

## 3. CD4 Count Decline Over Time

**Description:** Line graph showing typical CD4 count progression in untreated HIV

**Graph Data:**
```
CD4 Count Decline in Untreated HIV

CD4 Count (cells/Î¼L)
1000 â”‚
 900 â”‚        *
 800 â”‚       *
 700 â”‚      *
 600 â”‚     *
 500 â”‚    *
 400 â”‚   *
 300 â”‚  *
 200 â”‚ *
 100 â”‚*
     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
       0   2   4   6   8  10  12
           Years Post-Infection

* = AIDS Diagnosis (CD4 <200)
```

**Visual Elements:**
- Red declining line
- Critical thresholds marked
- Time to AIDS indication
- Individual variation notes
- ART intervention overlay

---

## 4. WHO Clinical Staging Pyramid

**Description:** Hierarchical pyramid showing WHO HIV clinical stages

**Pyramid Structure:**
```
Stage 4: AIDS
Severe Symptoms & OIs
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 3: Advanced HIV               â”‚
â”‚ Weight loss, diarrhea, TB, etc.     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Stage 2: Mild HIV                   â”‚
â”‚ Weight loss, herpes zoster, etc.    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
    Stage 1: Asymptomatic
Persistent generalized lymphadenopathy
```

**Visual Elements:**
- Color gradient (green to red severity)
- Clinical manifestations listed
- CD4 count correlations
- Treatment urgency indicators

---

## 5. Indian HIV Prevalence Heat Map

**Description:** Interactive heat map of India showing state-wise HIV prevalence

**Data Visualization:**
- **High Prevalence (Red):** Nagaland (1.5%), Manipur (1.4%), Mizoram (1.2%)
- **Medium Prevalence (Orange):** Andhra Pradesh (0.8%), Karnataka (0.7%)
- **Low Prevalence (Yellow):** Most other states (0.1-0.3%)
- **Very Low (Green):** Kerala, Tamil Nadu (<0.1%)

**Additional Layers:**
- Urban vs rural prevalence
- High-risk group concentrations
- ART center locations
- Testing facility density

---

## 6. ART Regimen Comparison Chart

**Description:** Comparative table of first-line ART regimens

**Table Structure:**
```
ART Regimen Comparison

Regimen          Drugs                          Advantages                    Disadvantages
TLD             TDF/3TC/DTG                   High efficacy, once daily      Cost, DTG availability
TLE             TDF/3TC/EFV                   Low cost, proven efficacy      CNS side effects
AZT-based       AZT/3TC/EFV                   Alternative for TDF toxicity   Anemia, EFV effects

Key: TDF=Tenofovir, 3TC=Lamivudine, DTG=Dolutegravir, EFV=Efavirenz, AZT=Zidovudine
```

**Visual Elements:**
- Color-coded regimens
- Efficacy bars
- Side effect icons
- Cost indicators
- Indian availability status

---

## 7. Viral Load Suppression Timeline

**Description:** Timeline showing viral load response to ART

**Timeline Layout:**
```
ART Initiation Response

Viral Load (copies/mL)
1,000,000 â”‚          *
   100,000 â”‚         *
    10,000 â”‚        *
     1,000 â”‚       *
       100 â”‚      *
        50 â”‚     *
         0 â”‚*****
           â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
             0  1  2  3  6  12  24
                 Months on ART

* = Viral load measurements
Target: <1,000 copies/mL
```

**Visual Elements:**
- Logarithmic scale
- Target line at 1,000 copies/mL
- Individual response variations
- Adherence correlation
- Resistance development indicators

---

## 8. Opportunistic Infections by CD4 Count

**Description:** Bar chart showing OI risk at different CD4 levels

**Chart Data:**
```
Opportunistic Infections by CD4 Count

CD4 >500:    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘ Candidiasis (20%)
CD4 200-500: â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘ Tuberculosis (60%)
CD4 <200:    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ Pneumocystis (90%)
CD4 <50:     â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ Cryptococcus (95%)

0%        25%       50%       75%       100%
```

**Visual Elements:**
- Horizontal stacked bars
- Color coding by OI type
- CD4 threshold markers
- Prophylaxis initiation points
- Indian prevalence data

---

## 9. NACO Program Impact Dashboard

**Description:** Comprehensive dashboard showing HIV program metrics

**Dashboard Layout:**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ National AIDS Control Programme - Achievements â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ðŸŽ¯ New Infections: 66% â†“ (2007-2017)            â”‚
â”‚ ðŸ’Š ART Coverage: 80% of PLHIV                   â”‚
â”‚ ðŸ§¬ Viral Suppression: 90% among adherent        â”‚
â”‚ ðŸ©¸ Blood Safety: 100% screened                  â”‚
â”‚ ðŸ‘¶ PMTCT: 95% transmission prevention          â”‚
â”‚ ðŸ“ ICTCs: 1,381 centers nationwide              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Visual Elements:**
- Progress bars with targets
- Trend arrows and percentages
- Color-coded metrics (green = achieved)
- Time-based improvements
- Future target projections

---

## 10. Prevention Strategy Wheel

**Description:** Circular wheel showing integrated HIV prevention approaches

**Wheel Segments:**
- **Treatment as Prevention** (TasP)
- **Pre-Exposure Prophylaxis** (PrEP)
- **Post-Exposure Prophylaxis** (PEP)
- **Condom Promotion**
- **Harm Reduction** (for IDUs)
- **STI Management**
- **VMMC** (Voluntary Medical Male Circumcision)
- **Blood Safety**

**Visual Elements:**
- Color-coded segments
- Effectiveness percentages
- Integration arrows
- Indian program examples
- Target population indicators

---

## 11. ART Adherence Factors

**Description:** Multifactorial diagram showing adherence determinants

**Factor Categories:**
```
ART Adherence Factors

Individual Factors
â”œâ”€â”€ Health beliefs
â”œâ”€â”€ Self-efficacy
â”œâ”€â”€ Mental health
â””â”€â”€ Substance use

Medication Factors
â”œâ”€â”€ Side effects
â”œâ”€â”€ Regimen complexity
â”œâ”€â”€ Pill burden
â””â”€â”€ Taste/smell

Social Factors
â”œâ”€â”€ Family support
â”œâ”€â”€ Stigma/discrimination
â”œâ”€â”€ Disclosure status
â””â”€â”€ Economic factors

Healthcare Factors
â”œâ”€â”€ Provider relationship
â”œâ”€â”€ Clinic accessibility
â”œâ”€â”€ Drug availability
â””â”€â”€ Counseling quality
```

**Visual Elements:**
- Hierarchical tree structure
- Positive/negative factor indicators
- Intervention points
- Cultural adaptation notes
- Measurement tools

---

## 12. PMTCT Cascade

**Description:** Step-by-step cascade showing PMTCT program effectiveness

**Cascade Steps:**
```
PMTCT Program Cascade

Pregnant Women Identified: 100%
         â†“ 95%
HIV Tested in ANC
         â†“ 90%
HIV Positive Identified
         â†“ 85%
ART Initiated
         â†“ 80%
Viral Suppression Achieved
         â†“ 75%
Safe Delivery
         â†“ 70%
Infant Prophylaxis Given
         â†“ 65%
Infant HIV Testing Done
         â†“ 60%
HIV-Free Survival at 18 Months
```

**Visual Elements:**
- Waterfall chart design
- Drop-off percentages
- Intervention improvement points
- Indian program data
- Global comparison

---

## 13. Drug Resistance Pathways

**Description:** Flowchart showing development of HIV drug resistance

**Resistance Development:**
```
ART Initiation
      â”‚
      â–¼
Viral Suppression Achieved?
â”œâ”€ Yes â†’ Continue monitoring
â”‚
â””â”€ No â†’ Adherence assessment
         â”‚
         â–¼
     Poor Adherence?
     â”œâ”€ Yes â†’ Counseling & support
     â”‚
     â””â”€ No â†’ Drug resistance testing
              â”‚
              â–¼
         Resistance detected?
         â”œâ”€ Yes â†’ Regimen change
         â”‚
         â””â”€ No â†’ Pharmacokinetic assessment
```

**Visual Elements:**
- Decision tree structure
- Color coding (green = good, red = concerning)
- Testing algorithm
- Regimen switch options
- Prevention strategies

---

## 14. Psychosocial Impact Illustration

**Description:** Mind map showing psychosocial aspects of HIV

**Central Theme: HIV Diagnosis Impact**
```
HIV Diagnosis
        â”‚
        â”œâ”€ Emotional Response
        â”‚   â”œâ”€â”€ Shock & denial
        â”‚   â”œâ”€â”€ Depression & anxiety
        â”‚   â”œâ”€â”€ Anger & guilt
        â”‚   â””â”€â”€ Suicidal ideation
        â”‚
        â”œâ”€ Social Impact
        â”‚   â”œâ”€â”€ Stigma & discrimination
        â”‚   â”œâ”€â”€ Relationship changes
        â”‚   â”œâ”€â”€ Family rejection
        â”‚   â””â”€â”€ Workplace issues
        â”‚
        â”œâ”€ Behavioral Changes
        â”‚   â”œâ”€â”€ Adherence challenges
        â”‚   â”œâ”€â”€ Risk behavior modification
        â”‚   â”œâ”€â”€ Support group participation
        â”‚   â””â”€â”€ Disclosure decisions
        â”‚
        â””â”€ Coping Strategies
            â”œâ”€â”€ Counseling & therapy
            â”œâ”€â”€ Support networks
            â”œâ”€â”€ Spiritual coping
            â””â”€â”€ Resilience building
```

**Visual Elements:**
- Radial mind map design
- Color-coded impact areas
- Support intervention links
- Cultural context adaptations
- Positive coping pathways

---

## 15. Future HIV Research Directions

**Description:** Roadmap showing future HIV research and treatment goals

**Research Areas:**
```
HIV Research Roadmap 2025-2030

Cure Research
â”œâ”€â”€ Stem cell transplantation
â”œâ”€â”€ Gene therapy approaches
â”œâ”€â”€ Latency reversal agents
â””â”€â”€ Therapeutic vaccines

Treatment Innovations
â”œâ”€â”€ Long-acting injectables
â”œâ”€â”€ Implants and patches
â”œâ”€â”€ Nanotechnology delivery
â””â”€â”€ Personalized medicine

Prevention Technologies
â”œâ”€â”€ Next-gen PrEP
â”œâ”€â”€ HIV vaccines
â”œâ”€â”€ Microbicides
â””â”€â”€ Multipurpose technologies

Global Targets
â”œâ”€â”€ 95-95-95 by 2030
â”œâ”€â”€ Ending AIDS by 2030
â””â”€â”€ Sustainable development
```

**Visual Elements:**
- Timeline-based layout
- Research category icons
- Progress indicators
- Collaboration networks
- Funding and policy implications

---

## Technical Specifications for HIV Visualizations

**Format:** High-resolution PNG/SVG for digital use
**Color Scheme:** Red awareness ribbon theme (#FF0000, #FFFFFF)
**Typography:** Clear, readable fonts (Arial, Calibri)
**Accessibility:** High contrast, alt text descriptions
**Animation:** Where applicable, subtle transitions and highlights

---

## Implementation Guidelines

1. **Educational Use:**
   - Integrate with lecture slides
   - Use in case-based learning
   - Support online learning modules
   - Enhance student engagement

2. **Clinical Application:**
   - Display in ART centers
   - Use for patient education
   - Support counseling sessions
   - Guide treatment decisions

3. **Quality Standards:**
   - Medical accuracy verification
   - Cultural sensitivity review
   - Regular updates with new data
   - Student feedback incorporation

4. **Distribution Channels:**
   - Medical college libraries
   - NACO training materials
   - Healthcare provider resources
   - Patient education handouts

These visualizations transform complex HIV concepts into engaging, memorable graphics that enhance medical education and patient understanding.
